The ability of new sugar-modified derivatives of antitumor anthracycline, daunorubicin, to stimulate NAD(P)H oxidation in different cellular oxidoreductase systems: NADH dehydrogenase, NADPH cytochrome P450 reductase, and xanthine oxidase. [electronic resource]
- Oncology research 2004
- 469-74 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't